Key facts
- Notable investors include WindRose Health Investors.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Stellus Rx
- ·The full record, as it builds
Funding rounds
No funding rounds for Stellus Rx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Stellus Rx
Provider of personalized pharmacy services intended to serve patients, healthcare providers, and risk-bearing entities. The company offers clinical support and coordination, personalized health support, and delivery of medication after communication through video calls, chat, and other channels, thereby enabling customers transparent, unique, and individualized support from the pharmacy.
- Sector
- Healthcare
- HQ
- Plano, TX, United States
- Founded
- 2022
- Employees
- 40
- Website
- stellusrx.com/
- Ownership
- Privately Held (backing)
Stellus Rx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Stellus Rx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Stellus Rx in its N-PORT filings yet. We sweep new filings monthly.